Sharps Technology (STSS) Competitors $5.36 -0.04 (-0.74%) Closing price 04:00 PM EasternExtended Trading$5.36 0.00 (-0.09%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock STSS vs. IRIX, NXGL, ALUR, NAOV, DRIO, NRXS, XAIR, NXL, IINN, and BDMDShould you be buying Sharps Technology stock or one of its competitors? The main competitors of Sharps Technology include IRIDEX (IRIX), NexGel (NXGL), Allurion Technologies (ALUR), Nanovibronix (NAOV), DarioHealth (DRIO), NeurAxis (NRXS), Beyond Air (XAIR), Nexalin Technology (NXL), Inspira Technologies OXY B.H.N. (IINN), and Baird Medical Investment (BDMD). These companies are all part of the "medical equipment" industry. Sharps Technology vs. Its Competitors IRIDEX NexGel Allurion Technologies Nanovibronix DarioHealth NeurAxis Beyond Air Nexalin Technology Inspira Technologies OXY B.H.N. Baird Medical Investment IRIDEX (NASDAQ:IRIX) and Sharps Technology (NASDAQ:STSS) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, media sentiment, dividends, valuation and profitability. Which has higher earnings and valuation, IRIX or STSS? IRIDEX has higher revenue and earnings than Sharps Technology. IRIDEX is trading at a lower price-to-earnings ratio than Sharps Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIRIDEX$48.67M0.41-$8.91M-$0.43-2.74Sharps TechnologyN/AN/A-$9.30M-$1.88 thousand0.00 Does the media refer more to IRIX or STSS? In the previous week, IRIDEX had 4 more articles in the media than Sharps Technology. MarketBeat recorded 6 mentions for IRIDEX and 2 mentions for Sharps Technology. Sharps Technology's average media sentiment score of 1.88 beat IRIDEX's score of 1.06 indicating that Sharps Technology is being referred to more favorably in the news media. Company Overall Sentiment IRIDEX Positive Sharps Technology Very Positive Do institutionals and insiders hold more shares of IRIX or STSS? 20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 17.2% of Sharps Technology shares are owned by institutional investors. 7.4% of IRIDEX shares are owned by insiders. Comparatively, 0.2% of Sharps Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, IRIX or STSS? IRIDEX has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Comparatively, Sharps Technology has a beta of 2.15, indicating that its stock price is 115% more volatile than the S&P 500. Is IRIX or STSS more profitable? Sharps Technology has a net margin of 0.00% compared to IRIDEX's net margin of -10.95%. Sharps Technology's return on equity of -98.77% beat IRIDEX's return on equity.Company Net Margins Return on Equity Return on Assets IRIDEX-10.95% -293.27% -17.47% Sharps Technology N/A -98.77%-53.85% SummaryIRIDEX beats Sharps Technology on 7 of the 12 factors compared between the two stocks. Get Sharps Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for STSS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STSS vs. The Competition Export to ExcelMetricSharps TechnologyMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.53M$10.54B$5.55B$9.83BDividend YieldN/A1.97%4.62%4.11%P/E Ratio0.0020.0630.1526.03Price / SalesN/A24.84460.84105.55Price / CashN/A24.0537.7558.93Price / Book0.053.138.476.06Net Income-$9.30M$209.94M$3.26B$265.11M7 Day Performance11.43%8.82%3.56%2.90%1 Month Performance-6.46%9.93%5.97%3.99%1 Year PerformanceN/A-6.89%42.70%26.92% Sharps Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STSSSharps Technology1.4845 of 5 stars$5.36-0.7%N/AN/A$5.53MN/A0.003Positive NewsEarnings ReportGap UpIRIXIRIDEX0.9116 of 5 stars$1.29+2.0%N/A-33.7%$21.58M$48.67M-2.99120News CoverageEarnings ReportNXGLNexGel0.8178 of 5 stars$2.63-0.8%N/A-2.9%$20.12M$8.69M-5.8410News CoverageEarnings ReportGap DownALURAllurion Technologies1.5367 of 5 stars$2.69+3.1%$22.83+748.8%-86.8%$20.07M$32.11M-0.22501News CoverageGap DownNAOVNanovibronix0.3958 of 5 stars$7.73+0.1%N/A-88.6%$19.93M$2.56M-0.5720Stock SplitGap DownTrading HaltedDRIODarioHealth1.654 of 5 stars$0.39-21.9%$2.00+408.9%-55.2%$17.89M$27.04M-0.70200News CoverageGap UpNRXSNeurAxis3.397 of 5 stars$2.36-3.1%$7.00+197.2%-21.5%$16.99M$2.93M-1.2819News CoverageGap UpXAIRBeyond Air4.0103 of 5 stars$3.25+2.8%$25.50+684.6%-63.3%$15.08M$3.70M-0.2170News CoverageEarnings ReportAnalyst ForecastGap DownNXLNexalin Technology3.2406 of 5 stars$0.85-4.2%$5.00+486.2%-4.5%$14.86M$170K-1.123Earnings ReportUpcoming EarningsGap UpIINNInspira Technologies OXY B.H.N.2.5842 of 5 stars$1.18-2.1%$2.00+70.2%+30.6%$14.83MN/A0.0020Gap DownBDMDBaird Medical InvestmentN/A$2.11-2.3%N/AN/A$13.88MN/A0.00N/APositive News Related Companies and Tools Related Companies IRIDEX Competitors NexGel Competitors Allurion Technologies Competitors Nanovibronix Competitors DarioHealth Competitors NeurAxis Competitors Beyond Air Competitors Nexalin Technology Competitors Inspira Technologies OXY B.H.N. Competitors Baird Medical Investment Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STSS) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sharps Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sharps Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access